According to an in vivo study using a murine model (db+/db+) of diabetes, PDRN was effective in healing an incisional skin wound based on the findings that there were significant increases in the wound breaking strength as well as the expression of VEGF and CD31 after a 12-day course of daily injection of PDRN [32]. This evidence concerns the gene PECAM1 and diabetes mellitus.